今开:0.0041 | 昨收:0.0041 |
最高:0.0041 | 最低:0.0041 |
涨停价:0.0 | 跌停价:0.0 |
总市值:85059.0 |
Tanthius2013-09-25 06:08
LIST1,$Catalyst Pharmaceutical Partne(CPRX)$ ,$GTX(GTXI)$ ,$杰龙(GERN)$ ,$REVOLUTION LIGHTING TECHNOLO(RVLT)$ ,$龙腾矿业(LLEN)$ ,$NEUTRAL TANDEM INC(IQNT)$ ,$阿库拉制药(ACUR)$ ,$真科生物技术(GNVC)$ ,$根科船务贸易(GNK)$ ,$伊格尔散货航运(EGLE)$查看全文
Tanthius2013-04-22 08:13
这周持续关注的Lisrt:$奥特控股(ADAT)$ ,$Biocryst医药(BCRX)$ ,$Cytokinetics(CYTK)$ ,$Descartes Systems Group(DSCO)$ ,$乔斯牛仔裤(JOEZ)$ ,$Velti plc(VELT)$ ,$Athersys(ATHX)$ ,$ECOTALITY INC(ECTY)$ ,$奇景光电(HIMX)$ ,$阿库拉制药(ACUR)$ ,$OCZ(OCZ)$ ,$Affymax(AFFY)$ ,$艾菲矩阵(AFF...查看全文
$阿库拉制药(ACUR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-20-041579 Act: 34 Size: 99 KB 网页链接
$阿库拉制药(ACUR)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001104659-20-040631 Act: 34 Size: 20 KB 网页链接
$阿库拉制药(ACUR)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001104659-20-040632 Act: 34 Size: 6 MB 网页链接
$阿库拉制药(ACUR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-20-034713 Act: 34 Size: 97 KB 网页链接
$阿库拉制药(ACUR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001104659-20-026512 Act: 34 Size: 5 MB 网页链接
$阿库拉制药(ACUR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-20-019231 Act: 34 Size: 116 KB 网页链接
$阿库拉制药(ACUR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001104659-20-013529 Act: 34 Size: 5 MB 网页链接
$阿库拉制药(ACUR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-002280 Size: 11 KB 网页链接
$阿库拉制药(ACUR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-001565 Size: 8 KB 网页链接
$阿库拉制药(ACUR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-001567 Size: 8 KB 网页链接